Fred Turner is CEO of Curative, a company that’s just announced a head-scratching pivot: from COVID-testing company to large-group commercial health plan.
North America health insurance market accounted for more than 30% revenue share in 2018 owing to presence of numerous providers coupled with growing prevalence of chronic diseases.
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho